Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis.
about
High soluble endoglin levels do not induce endothelial dysfunction in mouse aorta.Endoglin-based biological therapy in the treatment of angiogenesis-dependent pathologies.The roles of endoglin gene in cerebrovascular diseases.Cell adhesion molecules and eNOS expression in aorta of normocholesterolemic mice with different predispositions to atherosclerosis.Is there any relationship between adipocytokines and angiogenesis factors to address endothelial dysfunction and platelet aggregation in untreated patients with preeclampsia?
P2860
Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis.
@en
Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis.
@nl
type
label
Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis.
@en
Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis.
@nl
prefLabel
Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis.
@en
Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis.
@nl
P2093
P50
P1476
Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis
@en
P2093
Eva Brcakova
Lenka Vecerova
Martina Slanarova
Zbynek Strasky
Zuzana Mullerova
P356
10.1016/J.PHRS.2011.03.008
P577
2011-04-02T00:00:00Z